AGM/EGMApr 27, 2026, 04:33 PM
SER to Hold Annual Meeting; Proposes Share Increase to 125M
AI Summary
Serina Therapeutics, Inc. announced its Annual Meeting of Stockholders to be held virtually on June 17, 2026. Key proposals include increasing authorized common stock from 40 million to 125 million shares and increasing the 2024 Equity Incentive Plan share reserve by 2 million shares. Shareholders will also vote on the election of three Class III directors, approval of common stock issuances related to Series A Preferred Stock conversion and Private Placement Securities exercise, and advisory votes on executive compensation and its frequency.
Key Highlights
- SER to hold Annual Meeting on June 17, 2026, as a virtual meeting.
- Proposes to increase authorized common stock from 40M to 125M shares.
- Seeks to increase shares for 2024 Equity Incentive Plan by 2M shares.
- Proposes approval for common stock issuance from Series A Preferred Stock conversion.
- Proposes approval for common stock issuance from Private Placement Securities exercise.
- Shareholders to vote on election of three Class III directors.
- Advisory vote on Named Executive Officer compensation and its frequency.
- Ratification of Frazier & Deeter, LLC as independent registered public accountants.
Price Impact
More from SER